Histone deacetylase inhibitors butyrate and bufexamac inhibit de novo HIV-1 infection in CD4 T-cells
C. Schölz, L. Chen, A. Zutz, O. T. Keppler, J. Philippou-Massier, H. Blum, T. Liebner, C. Choudhary
This study shows that HDAC inhibitors butyrate and bufexamac inhibit de novo HIV-1 infection in CD4 T-cells without reactivating latent virus.
bioRxiv · Apr 29, 2020 · PreprintMicrobiology